The long term objective of this proposal is to understand how prolactin
(PRL) regulates cell proliferation and differentiation. To study
multiple components along the PRL-stimulated mitogenic pathway, we
cloned and characterized the PRL receptor (PRL-R), a member of the
hematopoietin/cytokine receptor superfamily, and a panel of early
response genes (transcription factors, cytokines, cytokine receptors)
and delayed early response genes, such as RNUDC. The structure and
function of two of these genes will be analyzed: the PRL-R which
mediates the mitogenic effects of PRL, and RNUDC, whose synthesis is a
result of PRL-stimulated cellular proliferation. AIM number 1 analyzes
PRL-R domains involved in interacting with signaling proteins. How the
PRL-R intracellular domain tyrosine residues serve as docking sites
for recruiting the transcription factors Stat1 and Stat5 will be
examined by mutagenesis, transfection, gel sift and in vitro interaction
assays. The significance of PRL-R interaction with the enzyme 2',5-
oligoadenylate synthetase (OAS), which was identified as a PRL-R
interacting protein by yeast two-hybrid genetics, will be addressed.
PRL-R truncations will be used to determine the site of PRL-R/OAS
interaction, and OAS sense and anti-sense constructs will be used to
address potential OAS function in PRL-R signal transduction. AIM number
2 addresses RNUDC structure and function. Genetic complementation
studies in Aspergillus nidulans have shown that rat RNUDC is a
functional homologue of a nuclear movement protein in the fungus;
however, its function in mammalian cells is unclear. Our localization
of RNUDC staining to the centrosome/Golgi region suggests the exciting
possibility that RNUDC may play a role in centrosome/Golgi structure
and/or function. A series of biochemical, pharmacological, genetic and
immunofluorescence microscopy studies are outlined to determine the
cellular localization of RNUDC, and to address potential RNUDC function
by sense and anti-sense strategies in mammalian cells. Finally, the
identity of a 50 kDa RNUDC interacting protein will be determined by
microsequencing. These combined studies should provide new insights
into the signaling mechanisms, signaling molecules, and gene sequences
involved in PRL regulation of cell proliferation. On a broader scale,
these studies may elucidate important steps in cellular growth controls
and provide insights into neuroendocrine-immune system interactions.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Golgi apparatusbiological signal transductioncell proliferationcentrosomecytokine receptorsgel mobility shift assayhormone receptorhormone regulation /control mechanismimmunofluorescence techniquenucleic acid sequencephosphotransferasesprolactinprotein bindingprotein localizationprotein sequenceprotein structure functionregulatory genesite directed mutagenesistissue /cell culturetranscription factortransfectiontyrosineyeast two hybrid system
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
051113330
UEI
FXKMA43NTV21
Project Start Date
15-March-1998
Project End Date
31-March-2004
Budget Start Date
01-March-2001
Budget End Date
31-March-2004
Project Funding Information for 2001
Total Funding
$52,675
Direct Costs
$35,000
Indirect Costs
$17,675
Year
Funding IC
FY Total Cost by IC
2001
National Institute of Diabetes and Digestive and Kidney Diseases
$52,675
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3R01DK053176-04S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01DK053176-04S1
Patents
No Patents information available for 3R01DK053176-04S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01DK053176-04S1
Clinical Studies
No Clinical Studies information available for 3R01DK053176-04S1
News and More
Related News Releases
No news release information available for 3R01DK053176-04S1
History
No Historical information available for 3R01DK053176-04S1
Similar Projects
No Similar Projects information available for 3R01DK053176-04S1